News
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
Interest in what caused the coronavirus pandemic has many political dimensions today, with President Trump saying genetic ...
The American College of Obstetricians and Gynecologists is urging insurers to continue covering vaccinations during pregnancy in an open letter signed by 30 prominent professional health organizations ...
Some of the panel's new members are anti-vaccine or clearly focus their attention on adverse reactions to vaccines.
Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated with the ...
His latest action confirms his intention to delist specific vaccines, making them less affordable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results